HeartBeam (BEAT) has a profit margin of -Infinity%, below the Healthcare sector average of 15.52%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
HeartBeam (BEAT) currently reports a profit margin of -Infinity% as of March 2026. That is below the Healthcare sector average of 15.52%. Use the charts on this page to explore HeartBeam's profit margin history and peer comparisons.
HeartBeam's profit margin of -Infinity% is lower than the Healthcare sector average of 15.52%. That is roughly Infinity% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but HeartBeam's current -Infinity% should be judged against Healthcare norms (sector average: 15.52%) and against BEAT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -Infinity%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.52%. From there, open related valuation or income-statement pages for HeartBeam, and consider following BEAT for alerts when major investors trade the stock.
HeartBeam is classified in the Healthcare sector. On profit margin, it currently shows -Infinity% versus a sector average near 15.52%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BEAT with unrelated industries.